ASCO Collaborates in Launch of Crowd-Sourced Molecular Oncology Tumor Board Series


Get Permission

Richard L. Schilsky, MD, FACP, FASCO

We hope that this new educational program will foster learning about tumor molecular genomics in an engaging and interactive format fueled by real-world case studies.

—Richard L. Schilsky, MD, FACP, F

The ASCO University®, the College of American Pathologists (CAP), and the Association for Molecular Pathology (AMP) recently announced their collaboration to create the Molecular Oncology Tumor Board series, an online and user-driven resource designed to help cancer care providers with the interpretation and understanding of tumor molecular profiling tests and studies.

The new crowd-sourced series allows for maximum user input and interaction and encourages a multidisciplinary discussion of this rapidly growing area of cancer care. Access to the Molecular Oncology Tumor Boards will be available for free beginning this month through the ASCO Connection website, ASCOConnection.org.

“Understanding the results of tumor molecular profiling studies is challenging, and the field of cancer genomics is rapidly changing, with new information being generated at a dizzying pace,” said ASCO Chief Medical Officer Richard L. Schilsky, MD, FACP, FASCO. “All oncologists struggle to keep abreast of this information and to learn how to use tumor molecular profiling to deliver high-quality, personalized cancer care. We hope that this new educational program will foster learning about tumor molecular genomics in an engaging and interactive format fueled by real-world case studies.”

Each month the Molecular Oncology Tumor Boards will feature a case-based discussion involving genetic or genomics in the treatment of cancer. The open forum will allow participants to post questions or comments about the cases, engage in discussion, and compare approaches.

Two rotating faculty members, a medical oncologist and pathologist, will lead the case discussion each month, provide input, and, after 2 weeks of discussion, will post a summary of the case discussion that addresses actionable aberrations identified and treatment options available based on clinical parameters. The information provided in the case discussions is designed to be educational and is not intended to make treatment recommendations.

The Molecular Oncology Tumor Boards are available to anyone who creates an ASCO.org account and logs into ASCOConnection.org. Participants who complete and pass a short post-test can also earn Continuing Medical Education (CME) credit. ■



Advertisement

Advertisement



Advertisement